These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 35508567

  • 41. Small-molecule suppressors of Candida albicans biofilm formation synergistically enhance the antifungal activity of amphotericin B against clinical Candida isolates.
    You J, Du L, King JB, Hall BE, Cichewicz RH.
    ACS Chem Biol; 2013 Apr 19; 8(4):840-8. PubMed ID: 23387427
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Oral infections caused by yeasts in patients with head and neck cancer undergoing radiotherapy. Identification of the yeasts and evaluation of their antifungal susceptibility.
    Bulacio L, Paz M, Ramadán S, Ramos L, Pairoba C, Sortino M, Escovich L, López C.
    J Mycol Med; 2012 Dec 19; 22(4):348-53. PubMed ID: 23518170
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. [In vitro activity of amphotericin B, fluconazole and itraconazole against Candida glabrata strains isolated from clinical samples].
    Hüseyin A, Sancak B, Arikan S.
    Mikrobiyol Bul; 2007 Apr 19; 41(2):235-44. PubMed ID: 17682710
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Yeasts isolated from nosocomial urinary infections: antifungal susceptibility and biofilm production.
    de Freitas AR, Baeza LC, Faria MG, Dota KF, Godoy Martínez P, Svidzinski TI.
    Rev Iberoam Micol; 2014 Apr 19; 31(2):104-8. PubMed ID: 23810785
    [Abstract] [Full Text] [Related]

  • 50. In vitro activity of anidulafungin in combination with amphotericin B or voriconazole against biofilms of five Candida species.
    Valentín A, Cantón E, Pemán J, Fernandez-Rivero ME, Tormo-Mas MA, Martínez JP.
    J Antimicrob Chemother; 2016 Dec 19; 71(12):3449-3452. PubMed ID: 27543657
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. The newly synthesized thiazole derivatives as potential antifungal compounds against Candida albicans.
    Biernasiuk A, Berecka-Rycerz A, Gumieniczek A, Malm M, Łączkowski KZ, Szymańska J, Malm A.
    Appl Microbiol Biotechnol; 2021 Aug 19; 105(16-17):6355-6367. PubMed ID: 34410437
    [Abstract] [Full Text] [Related]

  • 56. Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans.
    Messier C, Grenier D.
    Mycoses; 2011 Nov 19; 54(6):e801-6. PubMed ID: 21615543
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort.
    Samaranayake YH, Samaranayake LP, Tsang PC, Wong KH, Yeung KW.
    J Oral Pathol Med; 2001 Jul 19; 30(6):336-46. PubMed ID: 11459319
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Species distribution, antifungal susceptibility and clonal relatedness of Candida isolates from patients in neonatal and pediatric intensive care units at a medical center in Turkey.
    Kuzucu C, Durmaz R, Otlu B, Aktas E, Gulcan H, Cizmeci Z.
    New Microbiol; 2008 Jul 19; 31(3):401-8. PubMed ID: 18843896
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.